glutamic acid has been researched along with Non-alcoholic Fatty Liver Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, C; Anstee, QM; Arretxe, E; Brosnan, J; Dufour, JF; Gaggini, M; Gastaldelli, A; Hyötyläinen, T; Masoodi, M; Mato, JM; Millet, O; Orešič, M; Ortiz, P | 1 |
| Chen, D; Chen, X; Cheng, Y; Gu, R; Guan, C; Guo, C; Liang, J; Liang, Y; Qian, J; Qu, H; Shen, F; Wa, Y; Zhang, C | 1 |
| Chen, HW; Huang, CS; Jhuang, JH; Li, ML; Lii, CK; Liu, YT; Yao, HT | 1 |
| Endo, T; Fukuda, S; Hasegawa, T; Iino, C; Kimura, M; Mikami, K; Nakaji, S; Sawada, N | 1 |
| Castaño, GO; Flichman, D; Garaycoechea, M; Pirola, CJ; Sookoian, S | 1 |
| Adamski, J; Artati, A; Borggrefe, J; Franke, A; Freitag-Wolf, S; Höpfner, T; Hov, JR; Illig, T; Jacobs, G; Jensen, MK; Karlsen, TH; Kastenmüller, G; Koch, M; Krawczak, M; Lieb, W; Markus, MRP; Nöthlings, U; Nothnagel, M; Pick, J; Römisch-Margl, W; Schlesinger, S; Schreiber, S; Siegert, S | 1 |
| Abate, ML; Bugianesi, E; Buzzigoli, E; Carli, F; Cassader, M; Ciociaro, D; Della Latta, V; Gaggini, M; Gambino, R; Gastaldelli, A; Marietti, M; Rosso, C | 1 |
| Befroy, DE; Dufour, S; Petersen, KF; Rothman, DL; Shulman, GI | 1 |
| He, F; Jiang, Y; Li, H; Li, Y; Liu, Q; Wang, L; Wei, H; Yan, X; Yu, C; Zhang, X | 1 |
1 review(s) available for glutamic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.
Topics: Amino Acids; Bile Acids and Salts; Biomarkers; Disease Progression; Glutamic Acid; Glutathione; Humans; Insulin Resistance; Lipid Metabolism; Lipidomics; Metabolomics; Non-alcoholic Fatty Liver Disease; Prognosis | 2021 |
8 other study(ies) available for glutamic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Beneficial effects of Lactobacillus rhamnosus hsryfm 1301 fermented milk on rats with nonalcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Cholesterol; D-Aspartic Acid; Diet, High-Fat; Fatty Acids, Nonesterified; Glutamic Acid; Glycerides; Glycine; Lacticaseibacillus rhamnosus; Liver; Milk; Non-alcoholic Fatty Liver Disease; Oleic Acid; Rats; Reactive Oxygen Species; Rodent Diseases; Thymine | 2023 |
A Diterpenoid, 14-Deoxy-11, 12-Didehydroandrographolide, in
Topics: Alanine Transaminase; Andrographis; Animals; Antioxidants; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Diterpenes; Glutamic Acid; Lipid Peroxides; Liver; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Phytochemicals; Phytotherapy; Tumor Necrosis Factor-alpha | 2020 |
Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Cross-Sectional Studies; Female; Glutamic Acid; Glycine; Humans; Insulin; Insulin Resistance; Liver; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Risk Factors; Young Adult | 2020 |
Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aldehydes; Amino Acids, Branched-Chain; Cytochromes b; Disease Progression; DNA Damage; DNA, Mitochondrial; Glutamic Acid; Glutarates; Humans; Lipid Peroxidation; Liver; Middle Aged; Mutation; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Phosphorylation; Oxidative Stress; Severity of Illness Index; Transcriptome | 2021 |
Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample.
Topics: Aged; Alcohol Drinking; Biological Specimen Banks; Biomarkers; Cohort Studies; Computational Biology; Cross-Sectional Studies; Dipeptides; Expert Systems; Fatty Liver, Alcoholic; Female; Glutamic Acid; Humans; Lipid Metabolism; Liver; Magnetic Resonance Imaging; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Self Report; Severity of Illness Index | 2017 |
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.
Topics: Adult; Age Factors; Amino Acids; Biomarkers; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Humans; Insulin Resistance; Isoleucine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Tyrosine | 2018 |
Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by (13)C Magnetic Resonance Spectroscopy.
Topics: Adult; Anthropometry; Carbon; Carbon-13 Magnetic Resonance Spectroscopy; Case-Control Studies; Glutamic Acid; Humans; Liver; Male; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Pyruvic Acid; Time Factors | 2016 |
A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.
Topics: Adult; Animals; Biomarkers; Blood Glucose; Diet; Fatty Liver; Female; Glutamic Acid; Humans; Lactic Acid; Logistic Models; Magnetic Resonance Spectroscopy; Male; Metabolomics; Mice; Mice, Inbred C57BL; Middle Aged; Non-alcoholic Fatty Liver Disease; Principal Component Analysis; Taurine | 2011 |